The Center for Regenerative Medicine (CRM) at Massachusetts General Hospital, established in 2004, is at the forefront of exploring the vast medical potential of stem cell research.

It is dedicated to advancing the understanding of how tissues form and the mechanisms through which they can be repaired following injury or disease.

The CRM provides critical services in flow cytometry, light microscopy, and image analysis through its core facilities, supporting its research and discovery efforts. The center’s focus on regenerative medicine aims to foster innovations that can be translated into effective treatments for various medical conditions.